Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch to Genvoya in Virologically Suppressed HIV-1
NCT03493568Phase 3Terminated
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Feb 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir alafenamide in human immunodeficiency virus type 1 infection (HIV-1), sponsored by IRCCS Ospedale San Raffaele. Started Feb 2017; status: terminated.
02
Drugs
tenofovir alafenamide
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03493568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03493568.